Disclosure statement
C. da Cunha-Bang received consultancy fees and/or travel grants outside the current study from Astra Zeneca, Abbvie, and Gilead. C. U. Niemann has received research funding and/or consultancy fees from Abbvie, AstraZeneca, Janssen, CSL Behring, Takeda and the Novo Nordisk Foundation.